Coronavirus Puts The Brakes On Mylan-Upjohn Merger

Shareholders Meeting In The Netherlands Also Pushed Back

 
• By Dean Rudge
  
Delayed
Mylan and Pfizer's Upjohn had forecasted pro forma sales of up to $20bn this year • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business